<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">AJMB</journal-id>
			<journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
			<issn pub-type="ppub">2008-2835</issn>
			<issn pub-type="epub">2008-4625</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">AJMB-1-53</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Editorial</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Editorial</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Ardekani</surname>
						<given-names>Ali M.</given-names>
					</name>
					<degrees>Ph.D.</degrees>
					<role>Editor-in-Chief</role>
				</contrib>
			</contrib-group>
			<pub-date pub-type="ppub">
				<season>July-September</season>
				<year>2009</year>
			</pub-date>
			<volume>1</volume>
			<issue>2</issue>
			<fpage>53</fpage>
			<lpage>53</lpage>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2009 Avicenna Research Institute</copyright-statement>
				<copyright-year>2009</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
		</article-meta>
	</front>
	<body>
		<p>Welcome to the second issue of the AJMB. I hope you have read and enjoyed the first edition. In this issue, like the first one, there is a mix of articles covering a wide range of topics including: Promoter analysis, DNA immunization, synthesis of nanoparticles, non-coding RNAs and Intellectual property (IP) issues. I believe the article entitled "Biotechnology-Related IP Law of Iran" is the first article of its kind published in Iran in which a comprehensive review of Iranian laws pertaining to biotechnology is addressed. Therefore, I encourage those who are interested in patenting a discovery and/or product in the field of biotechnology in Iran to read this article.</p>
		<p>On different note, the sixth National Biotechnology Congress took place on 13-15 August, 2009 at the Milad Tower Convention Center in Tehran. This three day congress appeared to be one of the most successful congresses held in the field of biotechnology in Iran. It was understood that about 1000 abstracts were accepted and the majority of them were in the disciplines of agriculture, medicine and marine biology. It was interesting to learn that (according to a research carried out by the organizers of the congress) from a good number of articles published in the area of biotechnology in 2009 (and indexed by ISI), ninety nine articles belonged to the authors and research centers in Iran.</p>
		<p>As the editor, I would like to take the opportunity to invite all researchers in the field of medical biotechnology to send in their original research works, review articles, short articles, etc. for publication in the AJMB. The AJMB is now indexed in several databases worldwide and it is anticipated to be included in further lists in the near future.</p>
		<p>
			<italic>Ali M. Ardekani, Ph.D.</italic>
		</p>
		<p>
			<italic>Editor-in-Chief</italic>
		</p>
	</body>
</article>
